Similar articles

• Werner's classification of ocular changes in Graves's disease: a review.

  Lyle WM. Lyle WM. Am J Optom Physiol Opt. 1978 Feb;55(2):119-27. Am J Optom Physiol Opt. 1978. PMID: 354401 Review. No abstract available.
• [Association Budd Chiari syndrome, antiphospholipid syndrome and Grave's disease].

  Mouelhi L, Chaieb M, Debbeche R, Salem M, Sfar I, Trabelsi S, Gorgi Y, Najjar T. Mouelhi L, et al. Tunis Med. 2009 Feb;87(2):164-6. Tunis Med. 2009. PMID: 19522454 French.
• Dysthyroid ophthalmopathy.

  Kelman SE, Karesh JW. Kelman SE, et al. Am Fam Physician. 1986 Jul;34(1):167-78. Am Fam Physician. 1986. PMID: 3755279 No abstract available.
• What the internist should know about the ophthalmopathy of Graves' disease.

  Hamburger JI, Sugar HS. Hamburger JI, et al. Arch Intern Med. 1972 Jan;129(1):131-9. Arch Intern Med. 1972. PMID: 5066655 No abstract available.
• [Pathogenesis and management of Grave's ophthalmopathy].

  Wierzbowska J, Stankiewicz A. Wierzbowska J, et al. Klin Oczna. 2002;104(2):147-53. Klin Oczna. 2002. PMID: 12174459 Review. Polish.